ASPG and leukemia: Cell viability and proliferation assays did not demonstrate any significant changes (Figs. 4b and S4), and SOX11 knockdown did not have any impact on sensitivity to known leukemia drugs, such as dexamethasone, prednisolone, vincristine, and asparaginase (Fig. S5).